133 related articles for article (PubMed ID: 26939767)
1. Janus Kinase Inhibitors against Other Biological Treatments in Alopecia Areata.
Tavakolpour S
Scand J Immunol; 2016 May; 83(5):345-6. PubMed ID: 26939767
[No Abstract] [Full Text] [Related]
2. Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata.
Blume-Peytavi U; Vogt A
EBioMedicine; 2015 Apr; 2(4):282-3. PubMed ID: 26137570
[No Abstract] [Full Text] [Related]
3. Inhibiting Janus kinases to treat alopecia areata.
Divito SJ; Kupper TS
Nat Med; 2014 Sep; 20(9):989-90. PubMed ID: 25198048
[TBL] [Abstract][Full Text] [Related]
4. Blockage of T Cell Activation via Anti-CD40 and Anti-CD154 Monoclonal Antibodies can Possibility Treat Alopecia Areata.
Tavakolpour S; Daneshpazhooh M; Mahmoudi HR
Scand J Immunol; 2016 Jun; 83(6):463-4. PubMed ID: 26972309
[No Abstract] [Full Text] [Related]
5. IL-17 inhibition: is it the long-awaited savior for alopecia areata?
Ramot Y; Marzani B; Pinto D; Sorbellini E; Rinaldi F
Arch Dermatol Res; 2018 Jul; 310(5):383-390. PubMed ID: 29497840
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune disease: Getting to the root of hair loss in alopecia.
Bray N
Nat Rev Drug Discov; 2014 Oct; 13(10):724-5. PubMed ID: 25233992
[No Abstract] [Full Text] [Related]
7. Effects of mesenchymal stem cell therapy on alopecia areata in cellular and hair follicle organ culture models.
Kim JE; Oh JH; Woo YJ; Jung JH; Jeong KH; Kang H
Exp Dermatol; 2020 Mar; 29(3):265-272. PubMed ID: 30372797
[TBL] [Abstract][Full Text] [Related]
8. Two novel molecular mechanisms to account for the therapeutic efficacy of contact dermatitis against alopecia areata.
Namazi MR
Int Immunopharmacol; 2006 May; 6(5):862. PubMed ID: 16546718
[No Abstract] [Full Text] [Related]
9. Understanding autoimmunity of vitiligo and alopecia areata.
Rork JF; Rashighi M; Harris JE
Curr Opin Pediatr; 2016 Aug; 28(4):463-9. PubMed ID: 27191524
[TBL] [Abstract][Full Text] [Related]
10. Alopecia areata: topical immunotherapy--application and practical problems.
MacDonald N; Wiseman MC; Shapiro J
J Cutan Med Surg; 1999 Nov; 3 Suppl 3():S36-40. PubMed ID: 11776938
[No Abstract] [Full Text] [Related]
11. Effective squaric acid dibutylester immunotherapy is associated with a reduction of skin infiltrating T-helper (Th)1 and Th17 cells in alopecia areata patients.
Avitabile S; Sordi D; Garcovich S; Colonna L; De Luca A; Nasorri F; Mazzanti C; Cavani A
J Dermatol; 2015 Jan; 42(1):98-9. PubMed ID: 25495487
[No Abstract] [Full Text] [Related]
12. [Alopecia areata. Only an inflammation can still help].
Paukstadt W
MMW Fortschr Med; 2001 Sep; 143(39):8-10. PubMed ID: 11680931
[No Abstract] [Full Text] [Related]
13. Study of Th1/Th2 balance in peripheral blood mononuclear cells of patients with alopecia areata.
Sadeghi S; Sanati MH; Taghizadeh M; Mansouri P; Jadali Z
Acta Microbiol Immunol Hung; 2015 Sep; 62(3):275-85. PubMed ID: 26551570
[TBL] [Abstract][Full Text] [Related]
14. Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib.
Jabbari A; Dai Z; Xing L; Cerise JE; Ramot Y; Berkun Y; Sanchez GA; Goldbach-Mansky R; Christiano AM; Clynes R; Zlotogorski A
EBioMedicine; 2015 Apr; 2(4):351-5. PubMed ID: 26137574
[TBL] [Abstract][Full Text] [Related]
15. Therapy of alopecia areata: on the cusp and in the future.
Price VH
J Investig Dermatol Symp Proc; 2003 Oct; 8(2):207-11. PubMed ID: 14582675
[TBL] [Abstract][Full Text] [Related]
16. New targeted therapies in spondyloarthritis: what are the limits?
Wendling D
Immunotherapy; 2019 May; 11(7):557-560. PubMed ID: 30943857
[No Abstract] [Full Text] [Related]
17. An update on alopecia areata.
Kos L; Conlon J
Curr Opin Pediatr; 2009 Aug; 21(4):475-80. PubMed ID: 19502982
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune diseases: promising emerging therapies.
Vandenbark AA
J Invest Dermatol; 1995 May; 104(5 Suppl):10S-12S. PubMed ID: 7537781
[No Abstract] [Full Text] [Related]
19. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
Gilhar A; Kalish RS
Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
